Drug
PF 07275315
PF 07275315: highest development phase Phase 2, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| PF-07275315 NCT06977581 | Phase 2 | Asthma |
Latest
No recent events.
Follow PF 07275315 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.